Genomic & Biopharma NewsShort-term sleep loss affects cardiac function
Too little sleep takes a toll on your heart, according to a new study to be presented today at the annual meeting of the Radiological Society of North America.
|News Medical Life Sciences, 2016-12-02 12:55:18|
Chutes & Ladders: Pfizer’s longtime official Maddaluna retires as EVP
Chutes & Ladders: Pfizer’s longtime official Maddaluna retires as EVP aliu Fri, 12/02/2016 - 07:50
|Fierce Biotech, 2016-12-02 12:50:01|
Applying quantitative microscopy to live cells
Microscopy's got a long history. It was developed about 350 years ago for scientists to visualize things they could discern, but not describe. The two pioneers of microscopy were Antoine van Leeuwenhoek, who developed the first microscope and soon after the renowned scientist, Robert Hooke.
|News Medical Life Sciences, 2016-12-02 12:17:53|
Scientists devise new radiation-free probe for imaging molecules in the brain
Scientists hoping to get a glimpse of molecules that control brain activity have devised a new probe that allows them to image these molecules without using any chemical or radioactive labels.
|News Medical Life Sciences, 2016-12-02 11:57:34|
Clinical researchers in the Americas - could you win a coveted Pharma?
Clinical researchers in the Americas: demonstrate your skills and gain recognition for your achievements, whilst taking part in a valuable learning and development experience.
|PharmaTimes, 2016-12-02 10:54:17|
Virtual reality may help relieve phantom limb pain
In a recent study, patients experienced reduced phantom limb pain after playing an augmented reality car racing game that required them to move the missing limb.
|News Medical Life Sciences, 2016-12-02 10:39:00|
Four weeks of prehabilitation may help cancer patients to get in shape for surgery, study suggests
Just four weeks of prehabilitation may be enough to help some cancer patients get in shape for surgery.
|News Medical Life Sciences, 2016-12-02 10:36:40|
AZ, Bicycle pair up to develop bicyclic peptides
AstraZeneca and Bicycle Therapeutics have entered into a deal to develop bicyclic peptides that could net the latter firm more than $1 billion if all pre-specified targets are met.
|PharmaTimes, 2016-12-02 10:35:15|
MSD drops price of Keytruda for NICE nod
New data and a price reduction have helped secure a place for Keytruda on the NHS as a treatment for some patients with lung cancer.
|PharmaTimes, 2016-12-02 10:31:54|